It has been around a year since Beam Therapeutics slashed its headcount and R&D programmes to focus mainly on a sickle cell disease candidate – and the biotech has now revealed the first data with the ...

42 x 60 cm. (16.5 x 23.6 in.) Subscribe now to view details for this work, and gain access to over 18 million auction results. Purchase One-Day Pass ...